The unintended consequences of cervical screening: distress in women undergoing cytologic surveillance
Linda Sharp,Seonaidh Cotton,Margaret Cruickshank,Nicola M Gray,Kirsten Harrild,Louise Smart,Leslie G Walker,Julian Little,TOMBOLA Group,Maggie Cruickshank,Graeme Murray,David Parkin,Eric Walker,Norman Waugh,Mark Avis,Claire Chilvers,Katherine Fielding,Rob Hammond,David Jenkins,Jane Johnson,Keith Neal,Rashmi Seth,Dave Whynes,Ian Duncan,Alistair Robertson,Ian Russell,Breda Anthony,Sarah Bell,Adrienne Bowie,Katrina Brown,Joe Brown,Kheng Chew,Claire Cochran,Jeannie Dean,Kate Dunn,Jane Edwards,David Evans,Julie Fenty,Al Finlayson,Marie Gallagher,Nicola Gray,Maureen Heddle,Alison Innes,Debbie Jobson,Mandy Keillor,Jayne MacGregor,Sheona Mackenzie,Amanda Mackie,Gladys McPherson,Ike Okorocha,Morag Reilly,Joan Rodgers,Alison Thornton,Rachel Yeats,Lindyanne Alexander,Lindsey Buchanan,Susan Henderson,Tine Iterbeke,Susanneke Lucas,Gillian Manderson,Sheila Nicol,Gael Reid,Carol Robinson,Trish Sandilands,Marg Adrian,Ahmed Al-Sahab,Elaine Bentley,Hazel Brook,Claire Bushby,Rita Cannon,Brenda Cooper,Ruth Dowell,Mark Dunderdale,Gabrawi Li Guo,Lisa Heideman,Steve Jones,Salli Lawson,Zoë Philips,Christopher Platt,Shakuntala Prabhakaran,John Rippin,Rose Thompson,Elizabeth Williams,Claire Woolley,Massoud Boroujerdi,John Norrie,Nicholas Day,Theresa Marteau,Mahesh Parmar,Julietta Patnick,Ciaran Woodman,Doug Altman,Sue Moss,Michael Wells
DOI: https://doi.org/10.1097/LGT.0b013e31829c97d8
Abstract:Objective: It is well known that receipt of an initial abnormal cervical cytology test can trigger considerable anxiety among women. Less is known about the impact of follow-up by repeat cytology tests. We quantified prevalence, and identified predictors, of distress after repeat cytologic testing in women with a single low-grade test. Methods: Within the framework of the TOMBOLA randomized controlled trial of alternative managements, 844 women aged 20 to 59 years with a single routine cytology test showing borderline nuclear abnormalities (BNA; broadly equivalent to atypical squamous cells of undetermined significance) were assigned to follow-up by repeat cytology in primary care (the first test was due 6 months after the initial BNA result). Women completed sociodemographic and psychosocial questionnaires at recruitment and the Impact of Event Scale (IES) 6 weeks after their first follow-up cytology test. Factors associated with significant psychologic distress (IES ≥ 9) were identified using logistic regression. Results: The response rate was 74% (n = 621/844). Of all the respondents, 39% scored in the range for significant distress. Distress varied by follow-up cytology result: negative, 36%; BNA or mild dyskaryosis, 42%; other (including high grade and inadequate), 55%. After adjusting for the cytology result, risk of distress was significantly raised in women who had significant anxiety at recruitment, reported experiencing pain after the follow-up cytology, had children, or were dissatisfied with support they had received after their initial BNA test. Conclusions: Substantial proportions of women experience surveillance-related psychologic distress after a follow-up cytology test, even when the result is negative. This is an important, albeit unintended, consequence of cervical screening. Strategies to alleviate this distress merit attention.